1. Home
  2. DAIO vs LSTA Comparison

DAIO vs LSTA Comparison

Compare DAIO & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Data I/O Corporation

DAIO

Data I/O Corporation

HOLD

Current Price

$3.17

Market Cap

29.2M

Sector

Industrials

ML Signal

HOLD

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

HOLD

Current Price

$1.06

Market Cap

28.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAIO
LSTA
Founded
1969
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Misc Health and Biotechnology Services
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.2M
28.9M
IPO Year
2026
2000

Fundamental Metrics

Financial Performance
Metric
DAIO
LSTA
Price
$3.17
$1.06
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$5.22
$15.00
AVG Volume (30 Days)
38.4K
121.5K
Earning Date
05-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.42
EPS
N/A
N/A
Revenue
$21,500,000.00
$35,283,868.00
Revenue This Year
$4.51
N/A
Revenue Next Year
$30.29
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
56.90
52 Week Low
$2.16
$0.99
52 Week High
$4.49
$5.07

Technical Indicators

Market Signals
Indicator
DAIO
LSTA
Relative Strength Index (RSI) 37.55 19.37
Support Level $2.60 N/A
Resistance Level $3.26 $2.19
Average True Range (ATR) 0.19 0.20
MACD -0.00 -0.08
Stochastic Oscillator 29.31 3.23

Price Performance

Historical Comparison
DAIO
LSTA

About DAIO Data I/O Corporation

Data I/O Corp provides semiconductor programming, security provisioning, and intellectual property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices and secure microcontrollers. It operates as a single segment entity, with the sole objective to design, manufacture, and sell programming solutions and Programming-as-a-Service (PaaS) to the world's various electronics manufacturers including OEMs, CMs and EMS companies. The company operate in three separate locations Redmond, Washington; Shanghai, China; and Munich, Germany.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: